Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St’s investing ideas for FREE.

• If you are looking at Halozyme Therapeutics and wondering whether the current share price lines up with its underlying value, this article will walk through the key numbers so you can judge that for yourself.

• The stock recently closed at US$80.48, with returns of 0.3% over the past week, 13.0% over 30 days, 14.5% year to date, 39.0% over 1 year, 62.1% over 3 years and 70.5% over 5 years, which may have changed how some investors view its potential and risk profile.

• Recent coverage around Halozyme has focused on its role in the pharmaceuticals and biotech space and ongoing interest in its drug delivery platform,…